A product recently cleared by the U.S. Food and Drug Administration (FDA) and new to the medical device community addresses market needs but also questions for its developer.
Dr. Alec Goldenberg, M.D., a hematology and medical oncology specialist, is president of Medsol Corp., New York City, a fledgling company that has recently introduced an advanced bone marrow biopsy needle.
The needle took three years of development and resulted in a pair of patents for its inventor. Dr. Goldenberg took on the project after perceiving a need for the device.
"It wasn't too hard to realize that present needles are not adequate for a number of reasons," said …